RPC acquires Peracidin product line from Angelini Pharma

RPC acquired the Peracidin product line from Angelini Pharma on August 24, 2026, according to a statement. The product line consists of peroxyacetic and peracetic acid sterilants. Angelini Pharma is a pharmaceutical company that develops and commercializes branded pharmaceutical products, including sterilant and disinfectant formulations. The transaction adds the Peracidin brand to RPC's existing inventory of chemical products. Deal value was not disclosed.